Trichuris suis ova (TSO) as an additional therapy for rheumatoid arthritis patients with insufficient response to methotrexate. A prospective, double-blind, randomized, controlled monocenter study - TSORA
Phase of Trial: Phase II
Latest Information Update: 28 May 2019
At a glance
- Drugs Trichuris suis ova (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TSORA
- 31 Aug 2018 Biomarkers information updated
- 29 Jul 2016 Status changed from recruiting to discontinued.
- 11 Dec 2013 New source identified and integrated (German Clinical Trials Register; DRKS00005323).